Bayer v. Chronimed
This article was originally published in The Gray Sheet
Firms announce Dec. 7 settlement of patent litigation under which both parties will continue to market their products,and Chronimed's test strips will include a redesign of the DiaScreen leukocyte test. Bayer Diagnostics had filed suit in March 1999, alleging that the DiaScreen leukocyte test infringed its Multistix line of urine test strips (1"The Gray Sheet" March 15, 1999, p. 29)
You may also be interested in...
Chronimed's DiaScreen urinalysis test strips for leukocytes do not incorporate analytical processes or agents claimed in Bayer's U.S. patent covering glucose test strip technology, Chronimed maintains in a declaratory judgment action filed against Bayer in Minneapolis federal court.
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.